"Antipsychotic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
Descriptor ID |
D014150
|
MeSH Number(s) |
D27.505.696.277.950.040 D27.505.954.427.210.950.040 D27.505.954.427.700.872.331
|
Concept/Terms |
Antipsychotic Agents- Antipsychotic Agents
- Agents, Antipsychotic
- Antipsychotics
- Major Tranquilizers
- Tranquilizers, Major
- Tranquillizing Agents, Major
- Agents, Major Tranquillizing
- Major Tranquillizing Agents
- Neuroleptic Drugs
- Drugs, Neuroleptic
- Neuroleptics
- Tranquilizing Agents, Major
- Agents, Major Tranquilizing
- Major Tranquilizing Agents
- Antipsychotic Drugs
- Drugs, Antipsychotic
- Neuroleptic Agents
- Agents, Neuroleptic
Antipsychotic Effect- Antipsychotic Effect
- Effect, Antipsychotic
- Antipsychotic Effects
- Effects, Antipsychotic
|
Below are MeSH descriptors whose meaning is more general than "Antipsychotic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antipsychotic Agents".
This graph shows the total number of publications written about "Antipsychotic Agents" by people in this website by year, and whether "Antipsychotic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 3 | 0 | 3 |
1996 | 1 | 2 | 3 |
1997 | 1 | 2 | 3 |
1998 | 1 | 3 | 4 |
1999 | 1 | 1 | 2 |
2000 | 2 | 2 | 4 |
2001 | 4 | 2 | 6 |
2002 | 4 | 1 | 5 |
2003 | 2 | 3 | 5 |
2004 | 6 | 5 | 11 |
2005 | 9 | 2 | 11 |
2006 | 5 | 2 | 7 |
2007 | 7 | 5 | 12 |
2008 | 13 | 4 | 17 |
2009 | 10 | 3 | 13 |
2010 | 15 | 13 | 28 |
2011 | 12 | 4 | 16 |
2012 | 9 | 4 | 13 |
2013 | 12 | 9 | 21 |
2014 | 9 | 5 | 14 |
2015 | 10 | 5 | 15 |
2016 | 5 | 2 | 7 |
2017 | 10 | 8 | 18 |
2018 | 6 | 5 | 11 |
2019 | 7 | 1 | 8 |
2020 | 6 | 5 | 11 |
2021 | 5 | 0 | 5 |
2022 | 5 | 0 | 5 |
2023 | 13 | 0 | 13 |
2024 | 9 | 1 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antipsychotic Agents" by people in Profiles.
-
Drug-induced parkinsonism: diagnosis and treatment. Expert Opin Drug Saf. 2024 Dec; 23(12):1503-1513.
-
Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child Psychiatrists. J Child Adolesc Psychopharmacol. 2024 Oct; 34(8):359-365.
-
Adverse effects associated with antipsychotic use in older adults. Expert Opin Drug Saf. 2024 Sep; 23(9):1157-1171.
-
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms. Expert Rev Neurother. 2024 Oct; 24(10):1025-1033.
-
Acute Urinary Frequency in a Cancer Patient on Olanzapine. J Pain Symptom Manage. 2024 Oct; 68(4):e340-e342.
-
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges. Paediatr Drugs. 2024 Jul; 26(4):397-409.
-
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS Drugs. 2024 04; 38(4):239-254.
-
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics. J Child Adolesc Psychopharmacol. 2024 05; 34(4):201-209.
-
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents. J Clin Psychopharmacol. 2024 Mar-Apr 01; 44(2):124-132.
-
Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review. Curr Neuropharmacol. 2024; 22(14):2402-2421.